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Cardiovascular disease is the most common cause of mortality in the Western world and the 
majority of cardiovascular deaths are caused by coronary artery disease or cerebrovascular disease.  
Growth hormone (GH) is a growth-promoting hormone synthesized by the pituitary. Most of the 
effects of GH are mediated by local- or liver-produced insulin-like growth factor-I (IGF-I) but GH 
receptors have been found in a number of extra-hepatic tissues, suggesting direct, IGF-I-
independent effects of GH. Synthetic and endogenous GH secretagogues (GHS) release GH from 
the pituitary and may also exert direct effects in various tissues. 
Recent data suggest the GH/IGF-I system to improve cardiac performance and to be tissue 
protective after myocardial infarction. In the brain, the activity of the GH/IGF-I axis has been 
suggested to improve cognitive function, to exert cell protection after ischemic injury and to 
stimulate neurogenesis. 
The aim of this thesis was to investigate direct proliferative and protective effects of compounds of 
the GH/IGF-I axis on cells or tissue from organs that are exposed to ischemic injury or 
degenerative disease, such as heart and brain. . 
Our results suggest that the GH/IGF-I axis is involved in the generation of new cells, both in the 
heart and in the brain, and that some of these effects are independent of IGF-I. More specifically, 
the synthetic GHS hexarelin and the endogenous GHS ghrelin were found to have proliferative 
effects both in rat cardiomyocyte-like cells and in adult rat hippocampal progenitor (AHP) cells in 
vitro. In addition, hexarelin exerted protective effects in AHP cells after induction of apoptosis. 
Furthermore, peripheral administration of bovine GH (bGH) to hypophysectomized rats in vivo had 
proliferative effects in several brain regions and a proliferative effect was also found when AHP 
cells were incubated with bGH in vitro. 
The results in this thesis may have potentially important clinical implications in ischemic and 
degenerative cardiac and cerebral disease, when cell protection and recruitment of new cells are 
desirable. 
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